c4b24f7e44e24485bc6299accca1fe9f1fa87c25
MGA.md
| ... | ... | @@ -1,6 +1,6 @@ |
| 1 | 1 | # MGA |
| 2 | 2 | ## Overview |
| 3 | -MGA acts as a transcriptional repressor and interacts with MYC, a well-known oncogene. Mutations in MGA have been described in DLBCL.<sup>1</sup> One study suggested MGA mutations were more common in DLBCLs in patients of African ancestry.<sup>2</sup> |
|
| 3 | +MGA acts as a transcriptional repressor and interacts with MYC, a well-known oncogene. Mutations in MGA have been described in DLBCL.<sup>1</sup> One study suggested MGA mutations were more common in DLBCLs in patients of African ancestry.<sup>2</sup> The mutation pattern in MGA is consistent with a role as a tumour suppressor gene. |
|
| 4 | 4 | |
| 5 | 5 | ## Relevance tier by entity |
| 6 | 6 | |
| ... | ... | @@ -21,15 +21,10 @@ MGA acts as a transcriptional repressor and interacts with MYC, a well-known onc |
| 21 | 21 | |
| 22 | 22 | |Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)| |
| 23 | 23 | |:------:|:----:|:---------------------:|:----------------:|:----------------:| |
| 24 | -|BL |No |No |2.443 | 3.733 | |
|
| 25 | 24 | |DLBCL |No |No |1.432 |12.504 | |
| 25 | +|BL |No |No |2.443 | 3.733 | |
|
| 26 | 26 | |FL |No |No |0.000 | 0.000 | |
| 27 | 27 | |
| 28 | - |
|
| 29 | -> [!NOTE] |
|
| 30 | -> First described in DLBCL in 2013 by [Zhang J](https://pubmed.ncbi.nlm.nih.gov/23292937) |
|
| 31 | - |
|
| 32 | - |
|
| 33 | 28 | View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/MGA_protein.html) or [hg38](https://morinlab.github.io/LLMPP/GAMBL/MGA_protein_hg38.html) |
| 34 | 29 | |
| 35 | 30 |  |